Argá Medtech

Argá Medtech is a venture-backed development-stage company creating the next generation of pulsed field ablation and irreversible electroporation to safely and effectively treat patients with arrhythmias. Argá Medtech is developing the next generation of non-thermal cardiac ablation systems, which, when used with its proprietary catheter, offers unparalleled flexibility through its unique pulsed field ablation (PFA) generator. Argá has developed a new PFA platform called Coherent Sinusoidal Burst Electroporation (CSE), which provides greater flexibility in titrating lesion depth and ensuring transmural lesions. Its catheter offers the practicality of a single-shot device without losing its ability to create linear and focal lesions, eliminating the need for catheter exchanges during procedures.